Skip to Main Content

Author Details

Ivan Matic
Max Planck Institute for Biology of Ageing
2006
43
31
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36515834Immunoprecipitation Using Mono-ADP-Ribosylation-Specific Antibodies.Methods Mol Biol2023
37394344A chemical biology/modular antibody platform for ADP-ribosylation signaling.Trends Biochem Sci2023
37116497Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.Mol Cell2023
34323016ADP-ribosyltransferases, an update on function and nomenclature.FEBS J2022
36278281Hypoxia promotes osteogenesis by facilitating acetyl-CoA-mediated mitochondrial-nuclear communication.EMBO J2022
35963141The fast-growing business of Serine ADP-ribosylation.DNA Repair (Amst)2022
34285384Serine-ubiquitination regulates Golgi morphology and the secretory pathway upon Legionella infection.Cell Death Differ2021
34702826Structural basis for protein glutamylation by the Legionella pseudokinase SidJ.Nat Commun2021
33186521An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.Cell2020
29098880Specificity of reversible ADP-ribosylation and regulation of cellular processes.Crit Rev Biochem Mol Biol2018
30097874Nonlocalized Searching of HCD Data for Fast and Sensitive Identification of ADP-Ribosylated Peptides.Methods Mol Biol2018
30257210Interplay of Histone Marks with Serine ADP-Ribosylation.Cell Rep2018
29480802Serine is the major residue for ADP-ribosylation upon DNA damage.Elife2018
28520971Mass spectrometry for serine ADP-ribosylation? Think o-glycosylation!Nucleic Acids Res2017
28190768Serine ADP-Ribosylation Depends on HPF1.Mol Cell2017
28650317Serine ADP-ribosylation reversal by the hydrolase ARH3.Elife2017
28903997Mitotic post-translational modifications of histones promote chromatin compaction <i>in vitro</i>.Open Biol2017
27912065Phosphoribosylation of Ubiquitin Promotes Serine Ubiquitination and Impairs Conventional Ubiquitination.Cell2016
27634042Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor.J Biol Chem2016
27723750Serine is a new target residue for endogenous ADP-ribosylation on histones.Nat Chem Biol2016
25789582Processing of protein ADP-ribosylation by Nudix hydrolases.Biochem J2015
26292070Proteome-wide identification of SUMO modification sites by mass spectrometry.Nat Protoc2015
26166706Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens.Mol Cell2015
24782567Proteome-wide identification of SUMO2 modification sites.Sci Signal2014
25043379Family-wide analysis of poly(ADP-ribose) polymerase activity.Nat Commun2014
23481255Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.EMBO J2013
22370482The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions.Cell Cycle2012
23135281Mediator phosphorylation prevents stress response transcription during non-stress conditions.J Biol Chem2012
22847107Reanalysis of phosphoproteomics data uncovers ADP-ribosylation sites.Nat Methods2012
22350890Detection and quantitation of SUMO chains by mass spectrometry.Methods Mol Biol2012
21252943Purification and identification of endogenous polySUMO conjugates.EMBO Rep2011
21830832Absolute SILAC-compatible expression strain allows Sumo-2 copy number determination in clinical samples.J Proteome Res2011
21693764Comparative proteomic analysis identifies a role for SUMO in protein quality control.Sci Signal2011
20159558Regulation of translesion synthesis DNA polymerase eta by monoubiquitination.Mol Cell2010
21179022Defining the transcriptome and proteome in three functionally different human cell lines.Mol Syst Biol2010
20797634Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.Mol Cell2010
19107408Identification of SUMO target proteins by quantitative proteomics.Methods Mol Biol2009
19373234A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics.Nat Protoc2009
19471022System-wide changes to SUMO modifications in response to heat shock.Sci Signal2009
17938407In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.Mol Cell Proteomics2008
18565875The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.Mol Cell Proteomics2008
18707152Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution.J Proteome Res2008
17022104Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells.Proteomics2006
  • 1 - 43 of 43

Recommended Authors

Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
and the Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 1
College of Medicine, Yangzhou University
Career Start Year 2010
Number of shared co-authors 0
University of Southern Denmark
Career Start Year 2009
Number of shared co-authors 5
University of Konstanz Universitatsstrasse 10
Career Start Year 2009
Number of shared co-authors 2
J. David Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Institute of Translational Medicine, Swiss Federal Institute of Technology/ETH Zurich
Career Start Year 2004
Number of shared co-authors 0
The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 2003
Number of shared co-authors 5
Howard Hughes Medical Institute, University of California San Diego
Career Start Year 2003
Number of shared co-authors 0
University of California Irvine
Career Start Year 2003
Number of shared co-authors 0
ETH Zurich
Career Start Year 2002
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 3
University of Washington
Career Start Year 2001
Number of shared co-authors 1
Erasmus Medical Center
Career Start Year 2000
Number of shared co-authors 0
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS)
Career Start Year 1999
Number of shared co-authors 3
University of Dundee
Career Start Year 1999
Number of shared co-authors 2
Center for Biomedical Research Support, The University of Texas at Austin
Career Start Year 1999
Number of shared co-authors 0
Institute for Biotechnology, Technical University Berlin
Career Start Year 1998
Number of shared co-authors 6
Salk Institute for Biological Studies
Career Start Year 1998
Number of shared co-authors 0
University of Wisconsin-Madison College of Letters and Sciences
Career Start Year 1997
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1996
Number of shared co-authors 2
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1994
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1994
Number of shared co-authors 0
University of California Irvine
Career Start Year 1994
Number of shared co-authors 2
Harvard Medical School
Career Start Year 1991
Number of shared co-authors 3
IMP-Institute of Molecular Pathology
Career Start Year 1990
Number of shared co-authors 3
Cell Signaling Technology Inc.
Career Start Year 1987
Number of shared co-authors 0
Max Planck Institute for Multidisciplinary Sciences
Career Start Year 1982
Number of shared co-authors 1
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 5

Collaborators

Max-Planck Institute of Biochemistry
Co-authored papers 10
Max-Planck Institute of Biochemistry
Co-authored papers 4
Institute of Biochemistry II, Goethe University Frankfurt
Co-authored papers 3
Interfaculty Institute for Cell Biology, University of Tubingen
Co-authored papers 2
Institute of Hydrobiology, Chinese Academy of Sciences
Co-authored papers 2
University of Southern Denmark
Co-authored papers 2
Harvard T. H. Chan School of Public Health
Co-authored papers 1
King's College London
Co-authored papers 1
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
The University of Sheffield
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Bruker Daltonics GmbH & Co. KG
Co-authored papers 1
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 1
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers 1
University of Montpellier, CNRS
Co-authored papers 1
Department of Pharmaceutical Biosciences, Uppsala University
Co-authored papers 1
Tel Aviv University
Co-authored papers 1
Institute of Basic Medical Sciences, University of Oslo
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Kashubian Center for Heart and Vascular Diseases in Wejherowo, Pomeranian Hospitals
Co-authored papers 1
Co-authored papers 1
Albanova University Center, KTH - Royal Institute of Technology
Co-authored papers 1
Co-authored papers 1
University of Dundee
Co-authored papers 1